Dai S - Search Results

1

Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy.

Wang X, He Z, Liu W, Han R, Li H, Dai S, Zhang L, Mao M. Wang X, et al. Among authors: dai s. J Oncol. 2022 May 4;2022:9030782. doi: 10.1155/2022/9030782. eCollection 2022. J Oncol. 2022. PMID: 35571492 Free PMC article.

2

Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.

Zhang G, Liu WL, Zhang L, Wang JY, Kuang MH, Liu P, Lin YH, Dai SQ, Du J. Zhang G, et al. Clin Dev Immunol. 2011;2011:384726. doi: 10.1155/2011/384726. Epub 2011 Oct 13. Clin Dev Immunol. 2011. PMID: 22013481 Free PMC article.

3

Improved reverse screening algorithm for Treponema pallidum antibody using signal-to-cutoff ratios from chemiluminescence microparticle immunoassay.

Dai S, Chi P, Lin Y, Zheng X, Liu W, Zhang J, Zeng Q, Wu X, Liu W, Wang J. Dai S, et al. Sex Transm Dis. 2014 Jan;41(1):29-34. doi: 10.1097/OLQ.0000000000000066. Sex Transm Dis. 2014. PMID: 24326578

4

High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.

Chi PD, Liu W, Chen H, Zhang JP, Lin Y, Zheng X, Liu W, Dai S. Chi PD, et al. Among authors: dai s. PLoS One. 2014 Mar 13;9(3):e91080. doi: 10.1371/journal.pone.0091080. eCollection 2014. PLoS One. 2014. PMID: 24625581 Free PMC article.

5

Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.

Zheng X, Xing S, Liu XM, Liu W, Liu D, Chi PD, Chen H, Dai SQ, Zhong Q, Zeng MS, Liu WL. Zheng X, et al. Among authors: dai sq. BMC Cancer. 2014 Jul 7;14:490. doi: 10.1186/1471-2407-14-490. BMC Cancer. 2014. PMID: 25001061 Free PMC article.

6

Clinical Significance of Preoperative Albumin and Globulin Ratio in Patients with Gastric Cancer Undergoing Treatment.

Mao MJ, Wei XL, Sheng H, Wang XP, Li XH, Liu YJ, Xing S, Huang Q, Dai SQ, Liu WL. Mao MJ, et al. Among authors: dai sq. Biomed Res Int. 2017;2017:3083267. doi: 10.1155/2017/3083267. Epub 2017 Mar 23. Biomed Res Int. 2017. PMID: 28424782 Free PMC article.

7

A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma.

Wang XP, Mao MJ, He ZL, Zhang L, Chi PD, Su JR, Dai SQ, Liu WL. Wang XP, et al. J Cancer. 2017 Jul 5;8(11):2079-2087. doi: 10.7150/jca.19181. eCollection 2017. J Cancer. 2017. PMID: 28819409 Free PMC article.

8

Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.

Mao MJ, Xue N, Wang XP, Chi PD, Liu YJ, Huang Q, Dai SQ, Liu WL. Mao MJ, et al. BMC Cancer. 2018 Jan 2;18(1):9. doi: 10.1186/s12885-017-3718-2. BMC Cancer. 2018. PMID: 29295705 Free PMC article.

9

Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer.

Lai Y, Wang X, Zeng T, Xing S, Dai S, Wang J, Chen S, Li X, Xie Y, Zhu Y, Liu W. Lai Y, et al. Among authors: dai s. J Cancer. 2018 Apr 6;9(9):1538-1547. doi: 10.7150/jca.23973. eCollection 2018. J Cancer. 2018. PMID: 29760791 Free PMC article.

10

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.

Mao M, Wang X, Sheng H, Liu Y, Zhang L, Dai S, Chi PD. Mao M, et al. Among authors: dai s. BMC Cancer. 2018 Nov 28;18(1):1178. doi: 10.1186/s12885-018-5028-8. BMC Cancer. 2018. PMID: 30486825 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,845 results

Search Page

Filters